Industry
-
Indian PR giant buys control of SenateSHJ
- Fri Aug 21
Adfactors PR acquires a majority stake in SenateSHJ, a major provider of media and corporate affairs services to the ANZ pharma and MedTech sectors.
Read more -
ANZ head’s blunt message to pharma: adapt or die
- Wed Aug 19
Outgoing Takeda GM Dave Pearce’s advice on how to survive in a sector battling local and global pressures was the highlight of NEXT Pharma’s opening session.
Read more -
Global CEO slams Aussie pharma for failing to think differently
- Mon Aug 17
Lexicon Pharma CEO Professor Mike Exton says the ANZ industry has been stuck on the same PBS mantra for 20 years and it’s time they moved on.
Read more -
Pharma expert proposes radical access rethink
- Fri Aug 14
Incentives for biotechs to commercialise innovations in Australia along with a private funding model to bridge the gap between TGA registration and the PBS.
Read more -
AbbVie executives join MA, Pharmac
- Fri Aug 14
Jodie Wilson appointed to key policy role in MA’s senior team as NZ head moves to Pharmac in significant gains for the industry associations.
Read more -
GBMA pitches supply chain policy reform
- Mon Aug 10
White paper outlines proactive reforms to strengthen supply resilience, prevent shortages, and ensure patients aren’t left without their medicines.
Read more -
McCabe steps up as MA calls in the experts
- Mon Jul 27
McCabe moves into Dep Sect role as Medicines Australia appoints a strategic advisory firm to guide its negotiations with the government.
Read more -
Pharma’s AI optimism clashes with payer mistrust
- Fri Jul 24
PBAC chair likens the use of AI to giving the keys to a Ferrari to a 15-year-old and hoping they don’t kill themself. Will pharma and payers ever agree on AI?
Read more